Novo Nordisk (NVO)

Novo Nordisk (NVO) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

Market Sell-Off Weighs on Novo Nordisk Shares

Novo Nordisk slipped 1.4% today as the broader market fell harder, with the S&P 500 down 2.1% and the Nasdaq 100 down 3.8%. Shares have fallen 8.0% over the past week, while investors look toward the next report on Feb 3, 2027.

Published 2026-11-20 18:01:43 UTC.